Immune response to SARS-CoV-2 vaccination among chronic myeloid leukaemia patients on tyrosine kinase inhibitors.
Saved in:
| Title: | Immune response to SARS-CoV-2 vaccination among chronic myeloid leukaemia patients on tyrosine kinase inhibitors. |
|---|---|
| Authors: | Cheong CS; Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia., Ng LCD; Faculty of Medicine and Health Sciences, Universiti Malaysia Sarawak, Sarawak, Malaysia., Yap SH; Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia., Rajasuriar R; Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia., Arshad N; Department of Nursing, Universiti Malaya Medical Center, Kuala Lumpur, Malaysia., Zulhaimi NS; Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia., Kong BH; Department of Molecular Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia., Sam IC; Department of Medical Microbiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia., Bee PC; Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia., Kerishnan JP; Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia., Gan GG; Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia. |
| Source: | Annals of the Academy of Medicine, Singapore [Ann Acad Med Singap] 2026 Apr 08; Vol. 55 (4), pp. 179-188. Date of Electronic Publication: 2026 Apr 08. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Academy Of Medicine, Singapore Country of Publication: Singapore NLM ID: 7503289 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2972-4066 (Electronic) Linking ISSN: 03044602 NLM ISO Abbreviation: Ann Acad Med Singap Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
